Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1

被引:45
|
作者
Ataga, Kenneth I. [1 ,2 ]
Brittain, Julia E. [2 ,3 ]
Moore, Dominic [4 ]
Jones, Susan K. [1 ,2 ]
Hulkower, Ben [2 ]
Strayhorn, Dell [1 ,2 ]
Adam, Soheir [1 ,2 ]
Redding-Lallinger, Rupa [2 ,5 ]
Nachman, Patrick [6 ]
Orringer, Eugene P. [1 ,2 ]
机构
[1] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Comprehens Sickle Cell Program, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Div Nephrol & Hypertens, Chapel Hill, NC 27599 USA
关键词
hemophilia A; mutations; structure-function; factor VIII; GROWTH-FACTOR RECEPTOR; 3RD NATIONAL-HEALTH; RISK-FACTORS; RENAL-FUNCTION; CHILDREN; MICROALBUMINURIA; ADULTS; PREVALENCE; FAILURE; ANEMIA;
D O I
10.1111/j.1600-0609.2010.01471.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hemophilia A (HA) is a common X-linked recessive bleeding disease caused by mutations in FVIII gene. The identification of mutation in HA subjects can lead to more accurate diagnosis and contribute to the genetic counseling/prenatal diagnosis. Objectives: Our objective is to identify the FVIII defects in 148 unrelated Chinese HA subjects and to analyze the potential consequence of novel mutations. Methods: FVIII: C was assayed using one-stage method, and FVIII inhibitor was tested using Bethesda method. Intron 22 and 1 inversions were identified by PCR technique. Non-inversion mutations of FVIII gene were identified by direct sequencing. Novel mutations were further analyzed based on a B-domain deleted FVIII crystallographic structure and bioinformatics tools. Results: The intron 22 and 1 inversions affected 57 and three severe subjects, respectively. Sixty-seven different mutations were identified in non-inversion subjects including 35 novel mutations that were not reported previously. Novel mutations include five nonsense mutations, 15 missense mutations, three insertions, eight small deletions, two splice site mutations and two partial gene deletions. The potential deleterious effects of these novel missense mutations include disruption of the protein core, impairment of inter-domain interaction and FVIII binding with other proteins. Conclusion: Similar to other races, intron 22 and one inversions are also recurrent mutation in severe HA subjects monitored in our centre. Sixty-seven mutations (52% novel reported) among 88 non-inversion subjects represent the high degree of heterogeneity of FVIII gene mutations causing HA. Characteristic of HA FVIII gene mutations extend our insight into structure-function relationship of the FVIII molecule.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 50 条
  • [1] Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease
    Ataga, Kenneth I.
    Brittain, Julia E.
    Jones, Susan K.
    May, Ryan
    Delaney, John
    Strayhorn, Dell
    Desai, Payal
    Redding-Lallinger, Rupa
    Key, Nigel S.
    Orringer, Eugene P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (04) : 485 - 491
  • [2] SOLUBLE FMS-LIKE TYROSINE KINASE-1 IN YOUNG PATIENTS WITH SICKLE CELL DISEASE: RELATION TO HEMOLYSIS-ASSOCIATED COMPLICATIONS
    Tantawy, A. A.
    Adly, A. A.
    Ismail, E.
    Zeidan, M.
    HAEMATOLOGICA, 2014, 99 : 188 - 188
  • [3] Maternal Periodontal Disease and Soluble Fms-Like Tyrosine Kinase-1 Expression
    Horton, Amanda L.
    Boggess, Kim A.
    Moss, Kevin L.
    Beck, James
    Offenbacher, Steven
    JOURNAL OF PERIODONTOLOGY, 2009, 80 (09) : 1506 - 1510
  • [4] Soluble fms-like tyrosine kinase-1 and atherosclerosis in chronic kidney disease
    Luft, Friedrich C.
    KIDNEY INTERNATIONAL, 2014, 85 (02) : 238 - 240
  • [5] Hypertension in Response to Soluble FMS-Like Tyrosine Kinase-1 During Pregnancy: Role of Endothelin-1
    Murphy, Sydney
    LaMarca, Babbette
    Cockrell, Kathy
    Granger, Joey P.
    HYPERTENSION, 2009, 54 (04) : E35 - E36
  • [6] Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia
    Govender, Nalini
    Naicker, Thajasvarie
    Rajakumar, Augustine
    Moodley, Jagidesa
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 170 (01) : 100 - 105
  • [7] Serum soluble FMS-like tyrosine kinase-1 in ectopic pregnancy
    Selvarajan, Sathya
    Ramalingam, Jothimalar
    Vijayaraghavan, Jaya
    Bobby, Zachariah
    JOURNAL OF LABORATORY PHYSICIANS, 2019, 11 (04) : 335 - 339
  • [8] Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1)
    Youssry, Ilham
    Makar, Samuel
    Fawzy, Rania
    Wilson, Manal
    AbdAllah, Ghada
    Fathy, Eman
    Sawires, Happy
    PEDIATRIC NEPHROLOGY, 2015, 30 (12) : 2163 - 2168
  • [9] Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1)
    Ilham Youssry
    Samuel Makar
    Rania Fawzy
    Manal Wilson
    Ghada AbdAllah
    Eman Fathy
    Happy Sawires
    Pediatric Nephrology, 2015, 30 : 2163 - 2168
  • [10] Soluble fms-like tyrosine kinase 1
    Stepan, H
    Geide, A
    Faber, R
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21): : 2241 - 2242